Showing results (671-680 of 1,815) with videos related to
Sort By:
Pageof 182
Transplantation and Cellular Therapy|June 5, 2024
The Prevalence of Pretransplant Frailty and Mental Distress in Hematopoietic Cell Transplantation and Association with Clinical OutcomesShivjot Singh, Qing Cao, Connor Demorest, et al.Transplantation and Cellular Therapy|July 28, 2024
Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Zinaida Peric, et al.Transplantation and Cellular Therapy|July 6, 2024
Unsupervised Clustering Analysis of Regimen and HLA Characteristics in Pediatric Umbilical Cord Blood TransplantationMonica M Rivera-Franco, Liam Wynn, Fernanda Volt, et al.Transplantation and Cellular Therapy|July 6, 2024
Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group DatabaseChristopher P Venner, Peter Duggan, Kevin Song, et al.Transplantation and Cellular Therapy|July 7, 2024
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow TransplantationMadiha Iqbal, Ambuj Kumar, Peter Dreger, et al.Transplantation and Cellular Therapy|June 14, 2024
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell TherapyIbrahim Aldoss, Haoyue Shan, Dongyun Yang, et al.Transplantation and Cellular Therapy|May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell TherapiesRebecca A Gardner, Claire White, Magdi Elsallab, et al.Transplantation and Cellular Therapy|May 20, 2024
Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive ChemomobilizationAndrew J Portuguese, Albert C Yeh, Rahul Banerjee, et al.Transplantation and Cellular Therapy|May 20, 2024
Multiplexed Gastrointestinal PCR Panels for the Evaluation of Diarrhea in Hematopoietic Stem Cell Transplantation RecipientsClyde D Ford, Bert K Lopansri, Bradley D Hunter, et al.Transplantation and Cellular Therapy|August 22, 2023
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell LymphomaHanan Alkhaldi, Alec Reinhardt, Melissa Barnett, et al.Pageof 182